Cipla shares fall after FDA suspends license of Patalganga unit for 10 days
Cipla shares fell more than 1% in early trading on August 17 after the Konkan Food and Drug Administration (FDA) ordered the suspension of the license granted to the company’s Patalganga production unit for 10 days. in December 2023. The order was the result of non-compliance with good manufacturing practices at said facility under the …
Cipla shares fall after FDA suspends license of Patalganga unit for 10 days Read More »